According to Arizton’s latest research report, the metabolomics market will grow at a CAGR of 12.84% during 2022-2028. The rising trends in the metabolomics industry are the growing interest for metabolomics in plant & environmental studies, growing demand for metabolomics in food safety and quality control, and increasing funding for metabolomics research. Metabolomics is becoming an increasingly important tool for food safety and quality control due to its ability to analyze the chemicals produced by organisms as they interact with their environment. Metabolomics allows researchers and producers to assess food’s chemical composition, enabling them to detect potentially harmful substances and monitor the overall quality of food. Such factors are projected to affect the metabolomics market growth positively. Metabolomics can also identify adulterated foods, diagnose food-related illnesses, and determine the chemical composition of food-processing by-products. All these uses can help producers provide consumers with safer and higher-quality food products and help ensure compliance with food safety regulations.
Metabolomics Market Report Scope
| Report Attributes | Details |
| Market Size (2028) | USD 5.33 Billion |
| Market Size (2022) | USD 2.58 Billion |
| CAGR (2022-2028) | 12.84% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segmentation | Technologies, Application, End-user, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Market Dynamics |
|
Customize Your Report Now:
If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3859
North America to Contribute Larger Share in the Metabolomics Market
In 2022, North America accounted for the global metabolomics market’s highest revenue share, 40.37%. The surge in the adoption of personalized medicine due to the rise in chronic diseases, such as cardiovascular diseases, and the high mortality rate associated with genetic diseases are expected to drive market growth. The increase in R&D expenditure on initiatives for applications of metabolomics in personalized medicine and the rise in the number of instruments and reagents for proteomic research will also drive growth across North America.
The leading causes of death and disability contribute to $3.8 trillion in annual healthcare costs in the US. Every six in 10 adults in the country have a chronic disease, and four in 10 adults have two or more chronic diseases. The leading causes of mortality in the country include heart disease, cancer, chronic lung disease, stroke, Alzheimer’s disease, diabetes, and chronic kidney disease. The surge in the prevalence of chronic diseases has encouraged the country to shift its focus to adopting personalized medicine. The high R&D investments in metabolomics for biomarker discoveries and the development of personalized medicine in oncology due to the rise in the prevalence of cancer and other genetic diseases are expected to drive the growth of the US market. Companies such as Bruker, Life Technologies, Waters, and Thermo Fisher Scientific, provide various products, including diagnostic instruments, software, reagents, and kits for metabolomics research. Several US independent research groups and universities are also involved in metabolomics research.
Buy the Report Now: https://www.arizton.com/market-reports/metabolomics-market
Post-Purchase Benefit
- 1hr of free analyst discussion
- 10% of customization
Segmentation Insights
Insights by Technologies: The detection method technologies segment dominated the global metabolomics market, with a share of over 44% in 2022. Metabolomics is a powerful tool in biology and biochemistry, providing insights into the body’s metabolic and physiological processes. Over the last decade, technological advances have made metabolomics increasingly accessible and powerful. One important technology used in metabolomics is mass spectrometry. Mass spectrometry involves passing an ionized sample through a vacuum chamber, where it is broken down into its component elements. These mass spectra can then be used to identify and quantify the different metabolites present in a sample. Mass spectrometry is used in metabolomics to analyze complex metabolic mixtures and to determine the concentration of various metabolites in a sample.
Insights by Application: The global metabolomics market is segmented into medical & clinical research, plant & food science, and biotechnology. Metabolomics is an ever-growing field of research that is gaining increasing attention due to its potential in medical and clinical applications. The medical and clinical applications of metabolomics are numerous. They can be used to diagnose and monitor diseases and study the effects of drugs, toxins, and other environmental factors on health. Metabolomics can provide insight into the molecular basis of diseases and the mechanisms of the action of drugs. This information can be used to improve drug design and to identify novel therapeutic targets. Metabolomics can also be used to predict drug response in individuals and to identify biomarkers that can be used to evaluate health status. Such factors have helped the medical & clinical research application segment to dominate the global metabolomics market during the forecast period.
Insights by End-User: The standalone metabolomics service providers segment accounted for the largest global metabolomics market share 2022. Metabolomics service providers are becoming increasingly important in the field of research. By offering specialized services, such as sample preparation and analysis, data analysis and interpretation, and metabolite identification and quantification, these companies are helping researchers better understand how cells work and how diseases develop. As the demand for metabolomics services continues to grow, more companies are entering the market and offering specialized services to meet the needs of researchers.
Competitive Overview
The global metabolomics market is highly competitive and consists of several key players. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are major players that offer metabolomics products. The key global players focus on developing innovative technologies or methods and expanding their product portfolio through acquisitions to remain competitive. Most players continuously invest extensively in R&D and product development initiatives to expand their product portfolio and ensure a sustainable presence in the highly competitive environment. However, Vendors focus on developing and commercializing metabolomics instruments, reagents, consumables, and software to remain competitive and gain a significant presence in the market. New product approvals coupled with R&D activities help vendors to expand their presence, enhance market growth, and sustain their position in the global market. Vendors actively develop innovative metabolomics technologies to tap the tremendous growth potential in the market.
Market Segmentation
- Technologies: Detection Methods, Separation Methods, and Bioinformatics Tools & Services
- Application: Medical & Clinical Research, Plant & Food Science, and Biotechnology
- End-user: Standalone Metabolomic Service Providers, Pharma & Biotech Companies, Research & Clinical Laboratories, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Key Company Profiles
- Agilent Technologies
- Bio-Rad Laboratories
- Danaher
- PerkinElmer
- Thermo Fisher Scientific
Other Prominent Vendors
- Advion
- BGI
- biocrates life sciences
- Bruker
- LECO
- Merck KGaA
- SCION Instruments
- Shimadzu Corporation
- Waters
Metabolomics Service Providers
- Creative Proteomics
- Human Metabolome Technologies
- Metabolon
- Metaware Biotechnology
- MS-OMICS
- VProteomics
Get the Detailed TOC @ https://www.arizton.com/market-reports/metabolomics-market?details=tableOfContents
Table of Content
Proteomics Market – Global Outlook and Forecast 2022-2027
https://www.arizton.com/market-reports/proteomics-market
Genome Sequencing Market – Global Outlook and Forecast 2021-2026
https://www.arizton.com/market-reports/genome-sequencing-market-size-analysis
Cell and Gene Therapy Market – Global Outlook & Forecast 2022-2027
https://www.arizton.com/market-reports/cell-and-gene-therapy-market
Synthetic Biology Market – Global Outlook and Forecast 2022-2027
https://www.arizton.com/market-reports/synthetic-biology-market
Why Arizton?
- 100% Customer Satisfaction
- 24×7 availability – we are always there when you need us
- 200+ Fortune 500 Companies trust Arizton’s report
- 80% of our reports are exclusive and first in the industry
- 100% more data and analysis
- 1500+ reports published till date
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us
Call: +1-312-235-2040
+1 302 469 0707
Mail: enquiry@arizton.com
Contact Us: https://www.arizton.com/contact-us
Blog: https://www.arizton.com/blog
Website: https://www.arizton.com/